Literature DB >> 24583989

Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease.

Rutger J H Maas1, Jack F M Wetzels1, Jeroen K J Deegens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24583989     DOI： 10.1038/ki.2013.513

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  suPAR is the circulating factor in some but not all FSGS.

Authors:  Howard Trachtman; Jochen Reiser
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

2.  Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.

Authors:  Wolfgang Winnicki; Gere Sunder-Plassmann; Gürkan Sengölge; Ammon Handisurya; Harald Herkner; Christoph Kornauth; Bernhard Bielesz; Ludwig Wagner; Željko Kikić; Sahra Pajenda; Thomas Reiter; Benjamin Schairer; Alice Schmidt
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

3.  Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.

Authors:  Shui-Ming Guo; Min Han; Mei-Xue Chen; Yong Ning; Guang-Chang Pei; Yue-Qiang Li; Wei Dai; Shu-Wang Ge; Yuan-Jun Deng; Yan-Yan Guo; Xiao-Qing Li; Hermann Haller; Gang Xu; Song Rong
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

Review 4.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

5.  Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.

Authors:  Neus Roca; Elias Jatem; María Luisa Martín; Marina Muñoz; Maria Molina; Cristina Martínez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2020-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.